In Vitro Fertilization Market

The report "In Vitro Fertilization Market by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029", is projected to reach USD  1,650 million by 2029 from USD 949 million in 2024, growing at a CAGR of 11.7% during the forecast period. The expansion of the In vitro fertilization market is In vitro fertilization (IVF) has become widely adopted and utilized worldwide due to a combination of factors. A significant driver is an increase in the number of infertility cases, as a factor majorly linked to age-related fertility decline and changes in lifestyle or other medical conditions affecting fertility. All these factors put together enhance demand for IVF treatment among the sufferers of infertility problems at the individual or couple level.

Browse 249 market data Tables and 52 Figures spread through 280 Pages and in-depth TOC on "In Vitro Fertilization Market by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/in-vitro-fertilization-market-89198891.html

In vitro fertilization equipment segment to register a significant growth rate over the forecast period of 2024-2029.

Segmentation of the in vitro fertilization market by product: in vitro fertilization equipment, such as micromanipulators, imaging systems, incubators, laser systems, gas analyzers, etc.; consumables, reagents, and media; and accessories. Equipment used in any form of in vitro fertilization procedures is key to success and efficiency in the treatment of fertility problems. Microscopes are very important so that the sperm quality, maturity of the egg, and the development of the embryo can be evaluated properly. This enables the fertility specialists to enable their decisions at every step of the IVF process. Incubators provide the correct environment in terms of temperature, humidity, and gases for the survival of embryos at all stages of development. Centrifuges are the instruments are essential in sperm preparation as they eliminate seminal fluid from the sperm. This therefore helps in techniques like ICSI. Special instruments like embryo transfer catheters transfer and place an embryo into the uterus correctly and therefore help implantation.

By Cycle in the In vitro fertilization market in 2023.

In 2023, fresh non-donor IVF will have the largest market share. Fresh non-donor IVF is always in demand because it treats infertility using one's own eggs and sperm. Through this process, a person or couple could directly use his/her genetic materials chosen for cultural, familial, or personal reasons. Freshly retrieved eggs ensure better survival during implantation as compared to when frozen embryos are used. Fresh non-donor IVF represents the biggest market share, since it is cost-effective with a higher success rate when compared to those treatments using either egg donation or frozen embryos. Treatment using a patient's own eggs in a fresh cycle is generally more successful, besides eliminating extra costs and complications involved in finding and compensating egg donors. This also saves one from having to wait for either eggs or embryos to be thawed, thus making the treatment more prompt and time-saving. Also, technology has significantly enhanced the success rate for a fresh IVF cycle, which again makes it more amenable to patients. Additionally, the personalization involved in fresh IVF—because of the therapy's adjustment based on the patient's own fertility health—has made it very widely accepted. Its very affordability, effectiveness, rapid turnover, and, more importantly, direct control that a patient exercises over the treatment would bolster the dominance of the method in the fertility market.

Asia Pacific to account for a significant market share in the In vitro fertilization market in 2023.

The in vitro fertilization market, by region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest regional market in 2023. Asia-Pacific has indeed represented very high volumes of IVF procedures for a combination of compelling reasons. Already, across most countries in Asia Pacific, the incidence of infertility is increasing, perhaps largely due to delayed parenthood in both spouses for career and educational pursuits. The IVF market keeps dominating the Asia-Pacific region due to high population growth, rising cases of infertility, and rapid improvement in healthcare infrastructure. As economies—especially in China, India, and countries in Southeast Asia—are growing rapidly, higher disposable incomes are allowing more couples to afford advanced fertility treatments. Another factor is the rising awareness and acceptance of assisted reproductive technologies, fuelled by policies of governments sympathetic to healthcare investments. Moreover, there is a growing tendency toward modern medical facilities and highly qualified practitioners that ensure accessibility and quality with respect to IVF services. Cultural changes in terms of family planning, coupled with advances in medical technology, drive the leading role of this region within the global IVF market and turn it into a hub for local and international patients in their quest for fertility solutions.

As of 2023, prominent players in the In vitro fertilization market CooperSurgical inc.(US) Cook group(US) ,Vitrolife(Sweden),Hamilton thorne ltd.(US), Fujifilm Irvine scientific(Japan), among others.

Don’t miss out on business opportunities in In Vitro Fertilization Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]